Renal Fibrosis in Lupus Nephritis.

interstitial fibrosis lupus nephritis renal fibrosis systemic lupus erythematosus tubular atrophy

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Nov 2022
Historique:
received: 21 10 2022
revised: 14 11 2022
accepted: 16 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

Fibrosis can be defined as a pathological process in which deposition of connective tissue replaces normal parenchyma. The kidney, like any organ or tissue, can be impacted by this maladaptive reaction, resulting in persistent inflammation or long-lasting injury. While glomerular injury has traditionally been regarded as the primary focus for classification and prognosis of lupus nephritis (LN), increasing attention has been placed on interstitial fibrosis and tubular atrophy as markers of injury severity, predictors of therapeutic response, and prognostic factors of renal outcome in recent years. This review will discuss the fibrogenesis in LN and known mechanisms of renal fibrosis. The importance of the chronicity index, which was recently added to the histological categorization of LN, and its role in predicting treatment response and renal prognosis for patients with LN, will be explored. A better understanding of cellular and molecular pathways involved in fibrosis in LN could enable the identification of individuals at higher risk of progression to chronic kidney disease and end-stage renal disease, and the development of new therapeutic strategies for lupus patients.

Identifiants

pubmed: 36430794
pii: ijms232214317
doi: 10.3390/ijms232214317
pmc: PMC9699516
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Lupus. 2018 Aug;27(9):1455-1463
pubmed: 29759047
Nat Rev Nephrol. 2021 Mar;17(3):172-184
pubmed: 32989282
Science. 2022 Jan 07;375(6576):91-96
pubmed: 34990237
Nature. 2020 Jul;583(7814):127-132
pubmed: 32555459
Front Pharmacol. 2022 Apr 28;13:866077
pubmed: 35571122
Clin J Am Soc Nephrol. 2017 May 8;12(5):825-835
pubmed: 27821390
J Clin Invest. 2022 Jan 4;132(1):
pubmed: 34752423
Front Pharmacol. 2022 Jan 10;12:830340
pubmed: 35082683
Nat Med. 2013 Aug;19(8):1047-53
pubmed: 23817022
J Am Soc Nephrol. 2009 May;20(5):1103-12
pubmed: 19369404
J Clin Invest. 2007 Dec;117(12):3810-20
pubmed: 18037992
Clin Exp Immunol. 2020 May;200(2):120-130
pubmed: 31930484
PLoS One. 2015 Dec 02;10(12):e0143961
pubmed: 26630505
Am J Transplant. 2015 Apr;15(4):863-86
pubmed: 25691290
J Nephrol. 2021 Dec;34(6):1897-1905
pubmed: 33721269
Mod Rheumatol. 2020 Mar;30(2):225-231
pubmed: 31747840
N Engl J Med. 2014 May 29;370(22):2083-92
pubmed: 24836312
Cells. 2021 Aug 06;10(8):
pubmed: 34440782
Nat Rev Nephrol. 2016 Jun;12(6):325-38
pubmed: 27108839
Arthritis Care Res (Hoboken). 2011 Jun;63(6):865-74
pubmed: 21309006
Nature. 2019 Sep;573(7774):430-433
pubmed: 31511695
Kidney Int. 1996 Feb;49(2):461-9
pubmed: 8821830
Int J Mol Sci. 2018 Aug 27;19(9):
pubmed: 30150520
Autoimmunity. 2015;48(7):471-87
pubmed: 26099989
Nat Rev Nephrol. 2015 Apr;11(4):233-44
pubmed: 25584804
Nephrol Dial Transplant. 1999 Jan;14(1):58-63
pubmed: 10052478
J Clin Med. 2022 May 25;11(11):
pubmed: 35683365
N Engl J Med. 2015 Mar 19;372(12):1138-49
pubmed: 25785971
N Engl J Med. 2000 Oct 19;343(16):1156-62
pubmed: 11036121
Proc Am Thorac Soc. 2006 Jun;3(4):383-8
pubmed: 16738205
Arthritis Rheumatol. 2017 Apr;69(4):814-825
pubmed: 27992697
Clin Sci (Lond). 2019 Aug 5;133(15):1721-1744
pubmed: 31358596
Heart Fail Rev. 2016 Mar;21(2):199-211
pubmed: 26883434
Semin Arthritis Rheum. 2018 Feb;47(4):545-551
pubmed: 28803673
J Autoimmun. 1997 Oct;10(5):433-9
pubmed: 9376070
J Gerontol A Biol Sci Med Sci. 2006 Nov;61(11):1130-43
pubmed: 17167153
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14846-51
pubmed: 25267631
Front Immunol. 2021 Apr 20;12:676082
pubmed: 33959133
J Pathol. 2008 Jan;214(2):199-210
pubmed: 18161745
Rheumatology (Oxford). 2014 Dec;53(12):2249-58
pubmed: 24942493
Kidney Dis (Basel). 2021 Jan;7(1):34-49
pubmed: 33614732
Kidney Int. 1997 Feb;51(2):381-5
pubmed: 9027710
Clin Kidney J. 2018 Apr;11(2):207-218
pubmed: 29644061
Annu Rev Med. 2004;55:395-417
pubmed: 14746528
Nephrology (Carlton). 2011 Jul;16(5):522-35
pubmed: 21199156
Am J Transplant. 2010 Sep;10(9):2066-73
pubmed: 20883541
Curr Rheumatol Rep. 2021 Feb 10;23(3):16
pubmed: 33569681
Nat Rev Dis Primers. 2016 Jun 16;2:16039
pubmed: 27306639
Lupus. 2011 Nov;20(13):1396-403
pubmed: 22095887
Kidney Int. 1984 Apr;25(4):689-95
pubmed: 6482173
Nat Rev Dis Primers. 2017 Nov 23;3:17088
pubmed: 29168475
Nat Immunol. 2019 Jul;20(7):915-927
pubmed: 31110316
Kidney Int. 2018 Apr;93(4):789-796
pubmed: 29459092
Int J Rheum Dis. 2018 Feb;21(2):458-467
pubmed: 29314776
Kidney Int. 2002 Jul;62(1):31-40
pubmed: 12081561
Lupus Sci Med. 2022 Jan;9(1):
pubmed: 34996855
Cells. 2019 Jul 25;8(8):
pubmed: 31349698
Kidney Int Suppl (2011). 2014 Nov;4(1):34-38
pubmed: 26312148
J Am Soc Nephrol. 2010 Apr;21(4):646-53
pubmed: 20150539
Respir Res. 2014 Dec 12;15:157
pubmed: 25496490
Nat Rev Rheumatol. 2019 Dec;15(12):705-730
pubmed: 31712723
Kidney Int. 2006 Jan;69(2):213-7
pubmed: 16408108
Front Physiol. 2021 May 13;12:684236
pubmed: 34054586
Ren Fail. 2022 Dec;44(1):636-647
pubmed: 35387545
Kidney Int. 2010 May;77(9):820-9
pubmed: 20182417
Kidney360. 2021 Nov 5;3(1):122-132
pubmed: 35368572
Graefes Arch Clin Exp Ophthalmol. 2002 May;240(5):408-14
pubmed: 12073065
Am J Nephrol. 2021;52(3):180-189
pubmed: 33789284
J Immunol. 1995 May 1;154(9):4857-64
pubmed: 7722335
Nephrol Dial Transplant. 2000 Feb;15(2):184-90
pubmed: 10648663
J Am Soc Nephrol. 2015 Feb;26(2):258-69
pubmed: 25060060
JCI Insight. 2017 May 4;2(9):
pubmed: 28469080
J Autoimmun. 2015 Apr;58:111-22
pubmed: 25666976
Lancet. 2011 May 21;377(9779):1760-9
pubmed: 21571362
Arthritis Rheum. 2009 Jul;60(7):2071-82
pubmed: 19565476
Nat Rev Rheumatol. 2020 May;16(5):255-267
pubmed: 32203285
Kidney Int Rep. 2017 Apr 07;2(5):800-810
pubmed: 29270487
Nat Rev Nephrol. 2012 Feb 21;8(5):293-300
pubmed: 22349487
FASEB J. 2020 Feb;34(2):2554-2567
pubmed: 31909536
J Inflamm (Lond). 2019 Nov 14;16:22
pubmed: 31807119
Kidney Int. 2020 May;97(5):980-994
pubmed: 32143848
Clin J Am Soc Nephrol. 2007 Sep;2(5):906-13
pubmed: 17702727
Nat Rev Dis Primers. 2020 Jan 23;6(1):7
pubmed: 31974366
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1330-1342
pubmed: 31092014
Nat Rev Nephrol. 2019 Mar;15(3):144-158
pubmed: 30692665
J Clin Invest. 2007 Mar;117(3):524-9
pubmed: 17332879
Sci Rep. 2018 Jul 6;8(1):10231
pubmed: 29980727
Clin Sci (Lond). 2017 Jul 24;131(16):2125-2143
pubmed: 28646122
Am J Pathol. 2013 Jan;182(1):118-31
pubmed: 23142380
Oncogene. 2006 Dec 4;25(57):7469-81
pubmed: 17143291
Semin Arthritis Rheum. 2019 Dec;49(3):396-404
pubmed: 31277928
J Pharmacol Exp Ther. 2014 May;349(2):209-20
pubmed: 24556663
Case Rep Nephrol Dial. 2021 Jul 22;11(2):227-232
pubmed: 34414215
J Am Soc Nephrol. 2005 Apr;16(4):1076-84
pubmed: 15728784
Nat Med. 2013 Dec;19(12):1617-24
pubmed: 24216753
Clin Med Res. 2016 Mar;14(1):15-39
pubmed: 26847481
Arthritis Res Ther. 2018 Apr 10;20(1):64
pubmed: 29636091
Exp Mol Med. 2019 Jun 20;51(6):1-13
pubmed: 31221962
J Am Soc Nephrol. 2004 Jan;15(1):1-12
pubmed: 14694152
Respir Med. 2016 Apr;113:74-9
pubmed: 26915984
N Engl J Med. 2019 Oct 31;381(18):1718-1727
pubmed: 31566307
Clin J Am Soc Nephrol. 2017 May 8;12(5):734-743
pubmed: 28473317
Int Urol Nephrol. 2020 Jul;52(7):1287-1295
pubmed: 32378138
Circulation. 2003 Sep 23;108(12):1499-505
pubmed: 12952842
Front Immunol. 2020 Sep 23;11:578952
pubmed: 33072122

Auteurs

Savino Sciascia (S)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Martina Cozzi (M)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Alice Barinotti (A)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Massimo Radin (M)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Irene Cecchi (I)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Roberta Fenoglio (R)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Daniele Mancardi (D)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Georgia Wilson Jones (G)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Daniela Rossi (D)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Dario Roccatello (D)

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH